Sarah Kuehne

Publications

  1. 2020
  2. Accepted/In press
  3. Published
  4. Published
  5. Published
  6. Accepted/In press
  7. 2019
  8. Published
  9. Published
  10. Published

    Phosphorylation and functionality of CdtR in Clostridium difficile

    Sarah Kuehne, 1 Aug 2019, In : Anaerobe. 58, p. 103-109 7 p., 102074.

    Research output: Contribution to journalReview article

  11. Published

    Biofilm formation on polyetheretherketone and titanium surfaces

    Sarah Kuehne & Rachel Sammons, Aug 2019, In : Clinical and Experimental Dental Research. 5, 4, p. 427-437 11 p.

    Research output: Contribution to journalArticle

  12. Published
  13. Published
  14. 2018
  15. Accepted/In press

    Clostridial Genetics: Genetic Manipulation of the Pathogenic Clostridia

    Sarah Kuehne, 10 Dec 2018, (Accepted/In press) Clostridial Genetics: Genetic Manipulation of the Pathogenic Clostridia. American Society of Microbiology

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  16. E-pub ahead of print
  17. 2017
  18. E-pub ahead of print
  19. E-pub ahead of print
  20. Published
  21. 2016
  22. Published
  23. Published
  24. E-pub ahead of print
  25. E-pub ahead of print

    Clostridium difficile Genome Editing Using pyrE Alleles

    Sarah Kuehne, 10 Aug 2016, In : Methods in molecular biology. 1476, p. 35-52 18 p.

    Research output: Contribution to journalArticle

  26. Published
  27. Published

    Clostridium difficile flagella predominantly activate TLR5-linked NF-κB pathway in epithelial cells

    Sarah Kuehne, Apr 2016, In : Anaerobe. 38, p. 116-124 9 p.

    Research output: Contribution to journalArticle

  28. Published
  29. 2015
  30. Published
  31. Published

    The role of flagella in Clostridium difficile pathogenicity

    Sarah Kuehne, May 2015, In : Trends in Microbiology. 23, 5, p. 275-282 8 p.

    Research output: Contribution to journalArticle

  32. Published
  33. Published
  34. 2014
  35. Published
  36. Published
  37. Published
  38. Published

    Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

    Sarah Kuehne, 15 Apr 2014, In : OncoTarget. 5, 7, p. 1761-9 9 p.

    Research output: Contribution to journalArticle

  39. Published